切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - YES - Flk1

10 件产品

每页
清除全部
  1. SU6656
    B5839 SU6656
    Target: Src|Lyn|YES|Fyn
    Summary: Src 酪氨酸激酶抑制剂
      ≥18.55 mg/mL
      insoluble in H2O
  2. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
    中文名: 米哚妥林
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC抑制剂
      ≥57.1 mg/mL
      insoluble in H2O
  3. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  4. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  5. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  6. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  7. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  8. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    中文名: 布立尼布
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2的ATP竞争性抑制剂
      ≥18.5 mg/mL
      insoluble in H2O
  9. TAK-901
    A4124 TAK-901
    Target: Aurora Kinases|FLT3|Src|JAK|LRRK2|Hck|FGR|YES|Fyn|ARG
    Summary: Aurora A/B抑制剂
      ≥25.25 mg/mL
      insoluble in H2O
  10. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O

10 件产品

每页